Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reactive (secondary) amyloidosis and its pathogenesis.

Literature DB >> 6084866

Reactive (secondary) amyloidosis and its pathogenesis.

Abstract

Recent advances in amyloid research have broadened our understanding of amyloidogenesis in connection with chronic inflammatory and infectious conditions. Experimental and clinical studies have clarified many of the mechanisms of induction, synthesis and regulation of the amyloid-related serum component SAA and have shed light on the enzymatic processes involved in the cleavage of SAA and degradation of fibrillar AA protein. The current pathogenetic model emphasizes the dynamic character of amyloid disease.

Entities: Disease Gene

Mesh：

Substances：

Year: 1984 PMID： 6084866 DOI： 10.1007/bf00541358

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

106 in total

1. Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery.

Authors: P D Gorevic; C J Rosenthal; E C Franklin
Journal: Clin Immunol Immunopathol Date: 1976-07

2. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors: A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal: Proc Natl Acad Sci U S A Date: 1977-02 Impact factor: 11.205

3. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages.

Authors: B G Durie; B Persky; B J Soehnlen; T M Grogan; S E Salmon
Journal: N Engl J Med Date: 1982-12-30 Impact factor: 91.245

4. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors: K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal: J Clin Invest Date: 1978-02 Impact factor: 14.808

5. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors: R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal: Proc Natl Acad Sci U S A Date: 1975-04 Impact factor: 11.205

6. Amyloid A fibril degrading activity in serum in liver disease--relation to serum acute phase and other protein levels.

Authors: C P Maury; A M Teppo; M P Salaspuro
Journal: Clin Chim Acta Date: 1983-06-30 Impact factor: 3.786

7. The heterogeneity of protein AA in secondary (reactive)systemic amyloidosis.

Authors: P Westermark
Journal: Biochim Biophys Acta Date: 1982-02-04

8. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.

Authors: J S Hoffman; E P Benditt
Journal: J Biol Chem Date: 1982-09-10 Impact factor: 5.157

9. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors: G Lavie; D Zucker-Franklin; E C Franklin
Journal: J Exp Med Date: 1978-10-01 Impact factor: 14.307

10. Connective tissue origin of the amyloid-related protein SAA.

Authors: E Linder; R F Anders; J B Natvig
Journal: J Exp Med Date: 1976-11-02 Impact factor: 14.307

9 in total

Review 1. beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors: C P Maury
Journal: Rheumatol Int Date: 1990 Impact factor: 2.631

Reactive (secondary) amyloidosis and its pathogenesis.

1. Amyloid-related serum component (SAA)--studies in acute infections, medullary thyroid carcinoma, and postsurgery.

2. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

3. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages.

4. Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

5. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

6. Amyloid A fibril degrading activity in serum in liver disease--relation to serum acute phase and other protein levels.

7. The heterogeneity of protein AA in secondary (reactive)systemic amyloidosis.

8. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.

9. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

10. Connective tissue origin of the amyloid-related protein SAA.

Review 1. beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

2. Rheumatoid factors and amyloidosis in rheumatoid arthritis.

3. Case report 753. Tumoral amyloidosis at multiple sites.

4. Antibodies to amyloid A protein in rheumatic diseases.

5. Serologic evaluation of clinical and subclinical secondary hepatic amyloidosis in rhesus macaques (Macaca mulatta).

6. Urinary protein excretion patterns in reactive (secondary) systemic amyloidosis.

7. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.

8. Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis.

9. Secondary Gastrointestinal Amyloidosis Due to Bronchiectasis.